Non-small Cell Lung Cancer
- All
- News
-
Lung Cancer - Targeted Therapy Brings New Hope For Its Treatment, Says Expert
Targeted therapies use drugs or other substances to 'target' the cancer cells more precisely and avoid any damage to surrounding normal cells. Targeted therapy iseffective for non-small cell lung cancer.
-
Advancements In Treatment Therapies Bring Hope For Lung Cancer Patients
Small cell lung cancer (SCLC) and Non-small cell lung cancer (NSCLC) are two broad categories of lung cancer. NSCLC is the most common type which is accountable for more than 80% of the total lung cancer cases.
-
Triple-Therapy Treatment May Fight Resistant Lung Cancers: Study
A triple therapy treatment consisting of two experimental drugs and radiation therapy may help fight lung cancers that are resistant to current treatments, a new study has claimed.
-
Biomarker of Early Lung Cancer Identified
Researchers have identified a biomarker that detects the most common lung cancer in its earliest stage.
-
US Approves 'Breakthrough' Drug to Fight Lung Cancer
US authorities have approved a "breakthrough" drug to treat advanced non-small cell lung cancer, signalling a paradigm shift in the way the deadliest of all cancers is treated.
-
Lung Cancer - Targeted Therapy Brings New Hope For Its Treatment, Says Expert
Targeted therapies use drugs or other substances to 'target' the cancer cells more precisely and avoid any damage to surrounding normal cells. Targeted therapy iseffective for non-small cell lung cancer.
-
Advancements In Treatment Therapies Bring Hope For Lung Cancer Patients
Small cell lung cancer (SCLC) and Non-small cell lung cancer (NSCLC) are two broad categories of lung cancer. NSCLC is the most common type which is accountable for more than 80% of the total lung cancer cases.
-
Triple-Therapy Treatment May Fight Resistant Lung Cancers: Study
A triple therapy treatment consisting of two experimental drugs and radiation therapy may help fight lung cancers that are resistant to current treatments, a new study has claimed.
-
Biomarker of Early Lung Cancer Identified
Researchers have identified a biomarker that detects the most common lung cancer in its earliest stage.
-
US Approves 'Breakthrough' Drug to Fight Lung Cancer
US authorities have approved a "breakthrough" drug to treat advanced non-small cell lung cancer, signalling a paradigm shift in the way the deadliest of all cancers is treated.
